1Lemos PA, serruys PW,van Domburg RT,et al. Unrestricted utilization of sirolimus-eluting stents compared with conventional bare stent implantation in the " real world" : The Rapamycin-Eluting Stent Evaluated At Rotterdam Cardiology Hospital (RESEARCH) registry [J]. Circulation, 2004,109(2) :190 - 195.
2Orford JL, Lennon R, Melby S,et al, Frequency and correlates of coronary stent thrombosis in the mordern era: analysis of a single center registry[J]. J Am CoU Cardiol,2002,40(9) :1567 - 1572.
5Tolleson TR, Newby LK, Karrington RA, et al. Frequency of stent thrombosis after acute coronary syndrome (from the SYMPHONY and 2nd SYMPHONY trials) [ J ]. Am J Cardiol, 2003,92 ( 3 ) : 330 -333.
6Crines C, Cox D, Stone G,et al. coronary angioplasty with or without stent implantation for acute myocardial infarction, stent primarg angioplasty in myocardial infarction study group. [ J ]. N Engl J Med, 1999,341 (26) : 1949 - 1956.
7Moussa 1, Mario C, Reimers B,et al. Subacute stent thrombosis, in the era of intravascular ultrasound-guided coronary stenting without anticoagulation : frequency, predictors and clinical outcome [ J ]. J Am coU cardiol, 1997,29( 1 ) :6 - 12.
8Chieffo A, Bonizzoni E, Orlic D, et al. Intraprocedural stent thrombosis during implantation of sirolimus-eluting stents [ J ]. Circulation, 2004,109(22) :2732 -2736.
9Cheneau E, Leborgne L, Mintz GS. Predictors of subacute stent thrombosis: results of a systematic intravascular ultrasound study [ J ]. Circulation, 2003,108 ( 1 ) :43 - 47.
10Wang JC, Aucoin-Barry D, Manuelian D,et al. Incidence of aspirin nonresponsiveness using the Ultegra Rapid Platelet Function Assay ASA [ J ]. Am J Cardiol,2003,92 ( 12 ) : 1492 - 1494.
二级参考文献12
1Steinhubl SR, Berger PB, Mann JT 3rd, et al. Early and sustained dual oral antiplatelet therapy following percutaneous coronary intervention: a randomized controlled trial. JAMA, 2002, 288: 2411-2420.
2Chart AW, Molitemo DJ, Berger PB, et al. Triple antiplatelet therapy during percutaneous coronary intervention is associated with improved outcomes including one-year survival: results from the Do Tiroffixan and ReoProGive Similar Ettlcacy Outcome Trial (TARGET). J Am CollCardiol, 2003,42:1188-1195.
3Muller I, Seyfarth M, Rudiger S, et al. Effect of a high loading dose of clopidogrel on platelet function in patients undergoing coronary stent placement. Heart, 2001,85:92-93.
4Rao AK, Pratt C, Berke A, et al. Thrombolysis in Myocardial Infarction (TIMI) TriM-phase I: hemorrhagic manifestations and changes in plasma fibrinogen and the fibrinolytic system in patient streated with recombinant tissue plasminogen activator and streptokinase.J Am Coil Cardiol, 1988,11:1-11.
5Biondi-Zoeeai GG, Agostoni P, Testa L, et al. Increased mortality after coronary stenting in patients treated with clopidogrel without loading dose. Evidence from a meta-analysis. Minerva Cardioangiol,2004,52:195-208.
6Kastrati A, Mehilli J, Schuhlen H, et al. A clinical trial of abciximab in elective percutaneous coronary intervention after pretreatment with clopidogrel. N Engl J Med, 2004,350:232-238.
7Pache J, Kastrati A, Mehilli J, et al. Clopidogrel therapy in patients undergoing coronary stenting: value of a high-loading-dose regimen.Catheter Cardiovasc Interv, 2002,55:436--441.
8Gawaz M, Seyfarth M, Muller I, et al. Comparison of effects of clopidogrel versus ticlopidine on platelet function in patients undergoing coronary stent placement. Am J Cardiol. 2001. 87 : 332-336.
9Lemos PA, Serruys PW, van Domburg RT, et al. Unrestricted utilization of sirolimus-eluting stents compared with conventional bare stent implantation in the "real world": the Rapamycin-Eluting Stent Evaluated At Rotterdam Cardiology Hospital (RESEARCH) registry. Circulation, 2004,109:190-195.
10Moreno R, Fernandez C, Alfonso F, et al. Thrombosis after drug-eluting vs bare-metal stent implantation: a meta-analysis from 10 randomized trials including 5030 patients. Circulation, 2004,110:III-687. Abstract 3181.
